News | News By Subject | News by Disease News By Date | Search News

Psychosis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
The Filmmakers Behind 'Making A Murderer's' Next Project: Johnson & Johnson (JNJ) and Its Antipsychotic Drug Risperdal     6/17/2016
FDA Warns of Potential Safety Risk for Eli Lilly (LLY) Antipsychotic Drug Zyprexa     5/11/2016
Acadia (ACAD) Drug Approval May Make It an Attractive Target for Biogen (BIIB), Teva (TEVA)     5/9/2016
Otsuka America Pharma's Abilify Can Cause Urges to Gamble, Eat, Shop, Have Sex: FDA     5/5/2016
FDA Clears Acadia (ACAD)'s NUPLAZID, the First Drug for Psychosis Linked to Parkinson's     5/2/2016
Acadia (ACAD) Surges as FDA Panel Backs Psychosis Drug Linked to Parkinson’s Disease     3/30/2016
FDA Staff Says Acadia (ACAD)'s Drug for Parkinson's Disease Psychosis Nuplazid is Effective     3/28/2016
Deaths Review of Eli Lilly (LLY)'s Antipsychotic Zyprexa Relprevv "Inconclusive"     3/25/2015
Ex-FDA Chief Says Johnson & Johnson (JNJ) Knew Risperdal Caused Boys to Grow Breasts     1/29/2015
Pfizer (PFE)'s Antipsychotic Geodon Could Cause Fatal Skin Reaction: FDA     12/15/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Dr. Reddy's Laboratories Ltd. (RDY) Gets Nod to Launch Generic Seroquel in US     3/29/2012
FDA Warns of Severe Allergy Risk with Merck & Co., Inc. (MRK) Antipsychotic     9/6/2011
Massachusetts Sues Johnson & Johnson (JNJ) Over Risperdal Marketing     8/5/2011

News from Around the Web
Startup NeuroQore Uses Magnetic Pulses To Treat Depression. Does This Mean No More Drugs?     2/13/2017
Low Levels Of Exercise Worsens Psychosis, King's College London Study     8/26/2016
Stress Hormone Link With Psychosis, James Cook University Study Reveals     6/6/2016
Who Will Develop Psychosis? Automated Speech Analysis May Have The Answer, Columbia University Medical Center Study     8/27/2015
Can Fish Oil Slow Down Schizophrenia? University of Melbourne Study     8/13/2015
Development Of Psychosis: Gray Matter Loss And The Inflamed Brain, Yale University Study     1/14/2015
Injectable No Better than Oral Antipsychotics, Yale University Study     3/3/2011
Pot Can Double Psychosis Risk, New King's College London Study Says     3/2/2011
Cannabis Use Linked to Earlier Psychosis, University of New South Wales Study Finds     2/8/2011
Combating Weight Gain Caused By Antipsychotic Treatments, University of North Dakota Study     3/26/2009
Duke University Medical Center Scientists ID Pathway That Makes Antipsychotic Drugs Work; Finding Could Aid Drug Manufacturers In Development Of New Therapies     8/27/2008
AstraZeneca PLC (AZN) CEO in London Trial Will Take Stand Over Seroquel Diabetes Risk     6/20/2008
FDA Orders Black Box Warning Label on Older Antipsychotics     6/17/2008
Antipsychotic Drugs, Including Eli Lilly and Company (LLY)'s Zyprexa And Johnson & Johnson (JNJ)'s Risperdal, Triple Risk of Death for Dementia Patients     5/27/2008
Some Antipsychotic Drugs May be Missing Their Mark, Ohio State University Study     1/2/2008

Press Releases
Axim Biotech Enters Clinical Study Agreement With University of British Columbia To Begin Clinical Trial On CBD Chewing Gum For Treatment Of Drug-Related Psychosis     8/2/2017
Nobilis Receives A Notice Of Allowance For A Patent Covering Treatment Of Psychiatric Disorders With Noble Gases     6/13/2017
Brainsway (BRSYF.PK) Announces Positive Final Results Of Its Deep TMS Multicenter Study In Obsessive Compulsive Disorder (OCD) Patients     6/12/2017
Aequus Pharmaceuticals Announces Positive Results From Second Proof Of Concept Study For Long-Acting Aripiprazole Transdermal Patch     4/3/2017
Startup NeuroQore Uses Magnetic Pulses To Treat Depression. Does This Mean No More Drugs?     2/13/2017 Release: Update On The Treatment Of Parkinson’s Disease Psychosis     11/17/2016
Ajanta Pharma Announces the Launch of Aripiprazole Tablets     11/17/2016
Acadia (ACAD) Announces NUPLAZID (Pimavanserin) Is Now Available For The Treatment Of Hallucinations And Delusions Associated With Parkinson’s Disease Psychosis     5/31/2016
Acadia (ACAD) Appoints Julian C. Baker To Board Of Directors     12/15/2015
AVANIR Pharmaceuticals (AVNR) Announces Publication Of Study Evaluating The Prevalence Of Pseudobulbar Affect (PBA) Symptoms And Use Of Antipsychotic Medications In Nursing Homes     12/1/2015
Boehringer Ingelheim And BioMed X Extend Collaboration To Discover Novel Therapeutic Concepts For The Treatment Of Psychiatric Diseases     11/2/2015
Corcept Therapeutics Inc. (CORT) Release: Results Of Phase 1 Trial Of Next-Generation Cortisol Modulator CORT125134 To Be Presented At Annual Meeting Of American Association of Pharmaceutical Scientists     10/14/2015
Portage Biotech's Biohaven Completes Single Dose Phase Of Pharmacokinetic Trial With BHV-0223     9/22/2015
Transition Therapeutics Inc. (TTH.TO) Announces Fiscal 2015 Financial Results     9/16/2015
Allergan (AGN) And Gedeon Richter Ltd. (RIG2.F) To Present Data From Cariprazine Trials At European College Of Neuropsychopharmacology (ECNP) Annual Meeting In Amsterdam     8/25/2015